Results 241 to 250 of about 8,531 (253)
Some of the next articles are maybe not open access.
Cancer biomarkers: selecting the right drug for the right patient
Nature Reviews Drug Discovery, 2012Gary J Kelloff +2 more
exaly
Biomarkers and surrogate end points—the challenge of statistical validation
Nature Reviews Clinical Oncology, 2010Marc Buyse +2 more
exaly
Integrating predictive biomarkers and classifiers into oncology clinical development programmes
Nature Reviews Drug Discovery, 2011Robert A Beckman +2 more
exaly
Validation and clinical utility of prostate cancer biomarkers
Nature Reviews Clinical Oncology, 2013Howard I Scher, , Steven Larson
exaly
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Nature Reviews Cancer, 2016Suzanne L Topalian, Jänis M Taube
exaly
Identification and validation of biomarkers for autism spectrum disorders
Nature Reviews Drug Discovery, 2015Eva Loth +2 more
exaly
Proceedings of the Fifth Workshop on Resources and ProcessIng of linguistic, para-linguistic and extra-linguistic Data from people with various forms of cognitive/psychiatric/developmental impairments @LREC-COLING 2024
Iris E. Nowenstein +9 more
openaire +1 more source
Iris E. Nowenstein +9 more
openaire +1 more source
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
Nature Reviews Clinical Oncology, 2019D Ross Camidge +2 more
exaly

